# OTV

> OTV is a VC fund in Tel Aviv backing Health Care and Medical. See 22 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Tel Aviv, Israel
- Total investments: 22
- Last investment: Jul 2026
- Lead investor: 55%
- Fund size: $170M
- Last fund: Dec 2020
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/olive-tree-ventures
- Website: http://www.otv.vc

OTV is a global digital health fund with offices in Tel Aviv, NYC and Shanghai. The OTV mission is to invest in brilliant entrepreneurs, who are looking to touch the lives of those worldwide who will benefit from their innovative products and services in the digital health arena.

## Contacts

5 contacts available for OTV. Shizune tracks 7 team members at OTV. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/olive-tree-ventures?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $5M–$8M |
| Series A | $6M–$12M |
| Series B | $16M–$50M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 8 | 36% |
| Medical | 7 | 32% |
| Medical Device | 6 | 27% |
| Artificial Intelligence | 5 | 23% |
| Machine Learning | 3 | 14% |

36 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 5 | 23% |
| Series B | 4 | 18% |
| Seed | 3 | 14% |
| Series C | 3 | 14% |
| Funding Round | 2 | 9% |

8 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 8 | 36% |
| Israel | 6 | 27% |
| Ghana | 1 | 5% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Henry Weinstein | Investment Principal | 1 | https://shizune.co/investors/profile/henry-weinstein |
| Jose Antonio Urrutia Rivas | Head of Asia Pacific | 0 | https://shizune.co/investors/profile/jose-antonio-urrutia-rivas |
| Alejandro Weinstein | General Partner | 3 | https://shizune.co/investors/profile/alejandro-weinstein-2 |
| Amir Lahat | Co-Founder & General Partner | 3 | https://shizune.co/investors/profile/amir-lahat |
| Manor Zemer | Partner | 1 | https://shizune.co/investors/profile/manor-zemer |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| TytoCare | TytoCare is a mobile-health platform and device, allowing anyone to perform self physical examination and remote diagnosis.Tyto Care has three telehealth products: the TytoHome for consumers, TytoPro for professionals, and TytoClinic for remote point-of-care locations. All solutions are designed to replicate a facetious clinician visit andinclude a modular examination tool for examining the heart, lungs, skin, throat, ears, and body temperature; a complete telehealth platform for sharing exam data, conducting live video exams, and scheduling visits; a cloud-based data repository with analytics; and built-in guidance technology and machine learning algorithms to ensure accuracy and ease of use. TytoCare was founded by Dedi Gilad, Ofer Tzadik in 2012 with a vision to put health in the hands of the consumer. | $25M | Venture - Series Unknown | Jul 15, 2026 |  |
| Stake | Stake offers a platform for investing in US stocks and ETFs. The company provides account management, a Visa debit card, and cash back features. Banking services are provided by TransPecos Banks, SSB, and accounts may have pass-through deposit insurance if requirements are met. Users can track investments and manage funds through the Stakeplatform. | $12M | Series A | Jun 30, 2022 |  |
| Scopio | Scopio is an Online Community connecting photographers and visual artists to each other and to potential customers building the world's largest source of visual talent. Talented diverse artists from 190 countries have built profiles on Scopio, where they sell their images, tell their stories, and get hired for their visual art talent. Scopiopowers its platform using AI to give access to anyone, anywhere to participate. | $50M |  | Feb 10, 2022 |  |
| Scopio Labs | Scopio Labs is a provider of Full Field Morphology dedicated to unlocking the potential of imaging and AI in hematology. Uncovering actionable insights from vast amounts of data readily available in the average blood sample and bone marrow aspirate, Scopio's solutions will aim to showcase thousands of cells at scale in high resolution, toenable new hematology diagnostic methods. | $50M | Series C | Feb 09, 2022 |  |
| Scopio Labs | Scopio Labs is a provider of Full Field Morphology dedicated to unlocking the potential of imaging and AI in hematology. Uncovering actionable insights from vast amounts of data readily available in the average blood sample and bone marrow aspirate, Scopio's solutions will aim to showcase thousands of cells at scale in high resolution, toenable new hematology diagnostic methods. | $50M | Series C | Feb 09, 2022 |  |
| Aptihealth | aptihealth, inc. is a behavioral health engagement company that uses technology to seamlessly integrate physical and behavioral healthcare. Its groundbreaking platform connects medical providers, behavioral health specialists, behavioral health prescribers, and patients with its proprietary screening, assessment, and treatment management protocols.aptihealth’s digital platform provides a seamless and effective approach to virtual, intelligent integrated care that helps patients get better faster and stay better longer. aptihealth provides those in need of behavioral healthcare with a fast-track to better mental health. | $50M | Series B | Nov 17, 2021 |  |
| Campfire | Campfire is a new startup focused on 3D collaboration for design and engineering workflows. Led by pioneers of today’s most well-known augmented reality platforms, Campfire provides a new generation of devices and applications that enable globally distributed teams to work with 3D models as if sharing a central holographic projector. | $8M | Seed | Apr 27, 2021 |  |
| TytoCare | TytoCare is a mobile-health platform and device, allowing anyone to perform self physical examination and remote diagnosis.Tyto Care has three telehealth products: the TytoHome for consumers, TytoPro for professionals, and TytoClinic for remote point-of-care locations. All solutions are designed to replicate a facetious clinician visit andinclude a modular examination tool for examining the heart, lungs, skin, throat, ears, and body temperature; a complete telehealth platform for sharing exam data, conducting live video exams, and scheduling visits; a cloud-based data repository with analytics; and built-in guidance technology and machine learning algorithms to ensure accuracy and ease of use. TytoCare was founded by Dedi Gilad, Ofer Tzadik in 2012 with a vision to put health in the hands of the consumer. | $50M | Series D | Mar 04, 2021 |  |
| Medasense | Medasense (www.medasense.com) offers a breakthrough technology that enables clinicians to optimize and personalize pain control and avoid overmedicationMedasense’s flagship product, the PMD-200 with its NOL® index, is a unique platform that objectively monitors and quantifies the patient’s pain response by means of artificial intelligence and aproprietary non-invasive sensor platform. The PMD-200 is used to optimize pain management in operating rooms and critical care settings, where patients are unable to communicate – a $5B market. The company’s pipeline cloud-based solutions for clinics and home, leveraging the NOL technology, addresses an additional $15B global market.The PMD-200 is distributed in Europe exclusively by Medtronic (NYSE:MDT), is cleared for marketing also in Canada, Latin America and Australia, and enables connectivity with Philips patient monitors. Clinical studies have demonstrated its impact on patient safety and outcomes, including opioid-sparing.Medasense was founded in 2008 and based in Ramat Gan, Tel Aviv, Israel. | $18M | Series C | Sep 22, 2020 |  |
| Lemonaid Health | Lemonaid Health focuses on changing the patient experience and improving and optimizing clinical care through advancements in machine learning and AI. It leverages evidence-based guidelines and the most up-to-date clinical protocols to offer a service direct to consumers for less than typical co-pays.It was founded in 2013 and is headquartered inSan Francisco, California. | $36.8M | Series B | Jul 31, 2020 |  |

10 of 22 investments shown.

## Co-investors
- [OurCrowd](https://shizune.co/investors/profile/ourcrowd) — VC Fund, 4 deals together
- [Insight Partners](https://shizune.co/investors/profile/insight-partners) — VC Fund, 3 deals together
- [LR Group](https://shizune.co/investors/profile/lr-group) — VC Fund, 3 deals together
- [Qualcomm Ventures](https://shizune.co/investors/profile/qualcomm-ventures) — VC Fund, 3 deals together
- [Mizrahi Tefahot Bank](https://shizune.co/investors/profile/united-mizrahi-bank) — VC Fund, 3 deals together
- [Aurum Ventures MKI](https://shizune.co/investors/profile/aurum-ventures-mki) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [F6 Ventures](https://shizune.co/investors/profile/flat6labs) — VC Fund
- [Oqal](https://shizune.co/investors/profile/oqal) — VC Fund
- [Alesta Yatırım](https://shizune.co/investors/profile/alesta-girisim) — VC Fund

## Featured in investor lists
- [Medical Device Investors in Middle East](https://shizune.co/investors/medical-device-investors-middle-east)
- [Medical Device VC Funds in Middle East](https://shizune.co/investors/medical-device-vc-funds-middle-east)
- [Medical Device Investors in Israel](https://shizune.co/investors/medical-device-investors-israel)
- [Medical Device VC Funds in Israel](https://shizune.co/investors/medical-device-vc-funds-israel)
- [Health Care VC Funds in Israel](https://shizune.co/investors/health-care-vc-funds-israel)
- [Oil and Gas Investors in Israel](https://shizune.co/investors/oil-and-gas-investors-israel)

## FAQ

### What does OTV invest in?

OTV invests primarily in Health Care, Medical and Medical Device startups, most often at Series A and Series B stage. Most of the 22 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is OTV's check size?

OTV typically joins rounds of $5M–$8M at Seed, $6M–$12M at Series A and $16M–$50M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds OTV participates in.

### How do I contact OTV?

Public channels for OTV include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at OTV?

The team at OTV includes Henry Weinstein (Investment Principal), Jose Antonio Urrutia Rivas (Head of Asia Pacific) and Alejandro Weinstein (General Partner), among 7 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co